Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Precision Peptide CoPNGAF -5.22%22 EV-to-EBITDA is -6.37 as of Jul. 25, 2026. GuruFocus rates PNGAF with a GF Score™ of 22/100. The stock has 4 warning signs investors should review. Among 1,642 Consumer Packaged Goods companies, The Precision Peptide Co ranks worse than 60901.28% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, The Precision Peptide Co's enterprise value is $16.66 Mil.
The Precision Peptide Co's EBITDA for the trailing twelve months (TTM) ended in Apr. 2026 was $-2.62 Mil. Therefore, The Precision Peptide Co's EV-to-EBITDA for today is -6.37.
The historical rank and industry rank for The Precision Peptide Co's EV-to-EBITDA or its related term are showing as below:
PNGAF'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -8.82 Med: -3.31 Max: -0.37
Current: -6.28
During the past 5 years, the highest EV-to-EBITDA of The Precision Peptide Co was -0.37. The lowest was -8.82. And the median was -3.31.
PNGAF's EV-to-EBITDA is ranked worse than 100% of 1642
companies
in the Consumer Packaged Goods industry
Industry Median: 8.97
vs PNGAF: -6.28
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).
The Precision Peptide Co (OTCPK:PNGAF) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
The Precision Peptide Co's PE Ratio (TTM) for today is calculated as:
The Precision Peptide Co's share price for today is $0.34215.
The Precision Peptide Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.104.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Packaged Foods subindustry, The Precision Peptide Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
The Precision Peptide Co EV-to-EBITDA vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, The Precision Peptide Co's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where The Precision Peptide Co's EV-to-EBITDA falls into.
The Precision Peptide Co's current Enterprise Value is $16.66 Mil.
The Precision Peptide Co's EBITDA for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.62 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The Precision Peptide Co (PNGAF) has a EV-to-EBITDA of -6.37 as of Jul. 25, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on The Precision Peptide Co. According to the industry distribution chart, The Precision Peptide Co ranks #999999 out of 1642 companies in the Consumer Packaged Goods industry.
Is The Precision Peptide Co's EV-to-EBITDA too high?
The Precision Peptide Co's current EV-to-EBITDA is -6.37. Based on the distribution chart, The Precision Peptide Co ranks #999999 out of 1642 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, The Precision Peptide Co has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does The Precision Peptide Co's EV-to-EBITDA compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, The Precision Peptide Co ranks #999999 out of 1642 companies for EV-to-EBITDA. This places The Precision Peptide Co in the lower half of its industry. The industry median EV-to-EBITDA is 8.97. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Consumer Packaged Goods company?
The median EV-to-EBITDA among Consumer Packaged Goods companies is 8.97, based on 1,642 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on The Precision Peptide Co. For the Consumer Packaged Goods industry, the median EV-to-EBITDA is 8.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. The Precision Peptide Co's current EV-to-EBITDA is -6.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Precision Peptide Co stock overvalued right now?
The Precision Peptide Co (PNGAF) has a current EV-to-EBITDA of -6.37. The current EV-to-EBITDA is -6.37. The Precision Peptide Co's overall GF Score™ is 22/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For The Precision Peptide Co (PNGAF), the current EV-to-EBITDA is -6.37 as of Jul. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
The Precision Peptide Co Inc is a food manufacturer and distributor of nutritional supplements, functional snacks, natural foods, peptides, and natural personal care products. The company offers end-to-end services from formulation and ingredient sourcing to final packaging and fulfillment. The Company has two reportable operating segments: the manufacturing and distribution of food products in Canada and the sale and delivery of its peptide products in the United States.
22GF Score
Get the complete analysis for PNGAF
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PNGAF has been successfully added to your 
